COMPARATIVE EVALUATION OF THE CLINICAL EFFICACY OF LASERS IN PATIENTS WITH DIABETIC RETINOPATHY

Аннотация

Relevance. The most frequent, prognostically unfavorable specific vascular complication of DM is retinal
damage — diabetic retinopathy (DR). Moreover, patients of working age lose their vision [1].
The problem of early diagnosis and treatment of diabetic retinopathy continues to be one of the urgent problems
of modern ophthalmology, due to the late treatment of patients with diabetic retinopathy [2,3].
Diabetic retinopathy is the leading cause of blindness in people aged 20 to 65 years in most developing countries
of the world (Kohner E., 1992). Laser retinal coagulation has been proven to be the most effective treatment for
diabetic retinopathy. Laser treatment is aimed at stopping the functioning of newly formed vessels, which are
the main threat to the development of disabling changes in the visual organ: hemophthalmos, traction retinal
detachment, rubeosis (neovascularization) of the iris, secondary glaucoma. Timely and expertly performed laser
coagulation helps to preserve vision in the late stages of diabetic retinopathy in 55–65% of patients for 10–12years.
This indicator may be higher if treatment is initiated at an earlier stage [4].